down arrow

Eli Lilly & Co.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5324571083
USD
1,014.49
-19.07 (-1.85%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
45,042.70
34,124.10
28,541.40
28,318.40
24,539.80
22,319.50
24,555.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
45,042.70
34,124.10
28,541.40
28,318.40
24,539.80
22,319.50
24,555.70
Raw Material Cost
8,418.30
7,082.20
6,629.80
7,312.80
5,483.30
4,721.20
6,430.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
780.60
485.90
331.60
339.80
359.60
400.60
272.10
Selling and Distribution Expenses
8,593.80
7,403.10
6,440.40
6,431.60
6,121.20
6,213.80
6,631.80
Other Expenses
1,021.00
882.75
685.92
668.61
572.61
519.44
503.50
Total Expenditure (Excl Depreciation)
28,002.70
23,798.70
20,261.00
20,770.30
17,690.20
16,530.00
18,368.90
Operating Profit (PBDIT) excl Other Income
17040
10325.4
8280.4
7548.099999999999
6849.6
5789.5
6186.799999999999
Other Income
943.30
500.40
210.60
789.80
1,305.40
899.90
446.90
Operating Profit (PBDIT)
19,749.90
12,353.10
10,013.50
9,885.50
9,478.90
7,922.00
8,242.70
Interest
780.60
485.90
331.60
339.80
359.60
400.60
272.10
Exceptional Items
-4,522.30
-3,785.30
-1,353.00
-1,842.60
-565.50
-1,022.90
-2,565.90
Gross Profit (PBDT)
36,624.40
27,041.90
21,911.60
21,005.60
19,056.50
17,598.30
18,125.70
Depreciation
1,766.60
1,527.30
1,522.50
1,547.60
1,323.90
1,232.60
1,609.00
Profit Before Tax
12,680.40
6,554.60
6,806.40
6,155.50
7,229.90
5,265.90
3,795.70
Tax
2,090.40
1,314.20
561.60
573.80
1,036.20
628.00
563.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10,590.00
5,240.40
6,244.80
5,581.70
6,193.70
4,637.90
3,232.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10,590.00
5,240.40
6,244.80
5,581.70
6,193.70
4,637.90
3,232.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10,590.00
5,240.40
6,244.80
5,581.70
6,193.70
4,637.90
3,232.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
14,192.10
10,771.90
10,649.80
8,979.20
5,641.60
2,606.90
9,828.70
Earnings per share (EPS)
11.71
5.8
6.9
6.12
6.79
4.96
3.13
Diluted Earnings per share
11.71
5.8
6.9
6.12
6.79
4.96
3.13
Operating Profit Margin (Excl OI)
37.83%
30.26%
29.01%
26.65%
27.91%
25.94%
25.19%
Gross Profit Margin
32.07%
23.68%
29.18%
27.2%
34.86%
29.12%
22.01%
PAT Margin
23.51%
15.36%
21.88%
19.71%
25.24%
20.78%
13.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 32.00% vs 19.56% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 102.08% vs -16.08% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 58.67% vs 20.91% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 60.65% vs 46.53% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Eli Lilly & Co. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
45,042.70
88,819.00
-43,776.30
-49.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
45,042.70
88,819.00
-43,776.30
-49.29%
Raw Material Cost
8,418.30
27,862.00
-19,443.70
-69.79%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
780.60
1,150.00
-369.40
-32.12%
Selling and Distribution Expenses
8,593.80
22,869.00
-14,275.20
-62.42%
Other Expenses
1,021.00
1,611.50
-590.50
-36.64%
Total Expenditure (Excl Depreciation)
28,002.70
67,996.00
-39,993.30
-58.82%
Operating Profit (PBDIT) excl Other Income
17,040.00
20,823.00
-3,783.00
-18.17%
Other Income
943.30
3,255.80
-2,312.50
-71.03%
Operating Profit (PBDIT)
19,749.90
31,417.80
-11,667.90
-37.14%
Interest
780.60
1,150.00
-369.40
-32.12%
Exceptional Items
-4,522.30
-6,241.80
1,719.50
27.55%
Gross Profit (PBDT)
36,624.40
60,957.00
-24,332.60
-39.92%
Depreciation
1,766.60
7,339.00
-5,572.40
-75.93%
Profit Before Tax
12,680.40
16,687.00
-4,006.60
-24.01%
Tax
2,090.40
2,621.00
-530.60
-20.24%
Provisions and contingencies
0
0
0.00
Profit After Tax
10,590.00
14,066.00
-3,476.00
-24.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10,590.00
14,066.00
-3,476.00
-24.71%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10,590.00
14,066.00
-3,476.00
-24.71%
Equity Capital
0
0
0.00
Face Value
0.00
1.00
0.00
Reserves
14,192.10
71,490.00
-57,297.90
-80.15%
Earnings per share (EPS)
11.71
5.79
5.92
102.25%
Diluted Earnings per share
11.71
5.79
5.92
102.25%
Operating Profit Margin (Excl OI)
37.83%
23.44%
0.00
14.39%
Gross Profit Margin
32.07%
27.05%
0.00
5.02%
PAT Margin
23.51%
15.84%
0.00
7.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 4,504.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 32.00% vs 19.56% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 1,059.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 102.08% vs -16.08% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,880.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 58.67% vs 20.91% in Dec 2023

Annual - Interest
Interest 78.06 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 60.65% vs 46.53% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.83%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."